SIERRA ONCOLOGY, INC.
CIK 0001290149
Revenue (TTM)
$200K
+100.0% YoY
Q1 May 2022
Net Income (TTM)
−$97.12M
−425.2% YoY
Q1 May 2022
EPS Diluted (TTM)
—
Q1 May 2022
Gross Margin
—
Q1 May 2022
Operating Margin
-48,438.5%
Q1 May 2022
Net Margin
-48,560.0%
Q1 May 2022
Free Cash Flow (TTM)
−$72.55M
Q1 May 2022
Cash
$274.02M
Q1 May 2022
Total Debt
$5.03M
Q1 May 2022
Shares Outstanding
24.42M sh
Q1 May 2022
Revenue & Net Income
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.